<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Certain embolic <z:hpo ids='HP_0001297'>cerebrovascular accidents</z:hpo> can be explained by the development of <z:hpo ids='HP_0004757'>paroxysmal atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>When noninvasive complementary investigations are negative, programmed atrial stimulation can be proposed to detect increased atrial vulnerability </plain></SENT>
<SENT sid="2" pm="."><plain>The objective of this study was to evaluate the reliability of this method performed via a transoesophageal approach in 59 subjects presenting with an embolic <z:hpo ids='HP_0001297'>cerebrovascular accident</z:hpo> and who were in sinus rhythm at the time of the accident </plain></SENT>
<SENT sid="3" pm="."><plain>Seven of these patients had a history of <z:hpo ids='HP_0004757'>paroxysmal atrial fibrillation</z:hpo> (AF) or atrial <z:hpo ids='HP_0001649'>tachycardia</z:hpo> (AT) (group I) </plain></SENT>
<SENT sid="4" pm="."><plain>Three of these seven patients also presented AV nodal reentrant junctional <z:hpo ids='HP_0001649'>tachycardia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The other 52 patients had no history of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> and their Holter recording did not reveal any episodes of sustained atrial <z:hpo ids='HP_0001649'>tachycardia</z:hpo> (group II) </plain></SENT>
<SENT sid="6" pm="."><plain>Transoesophageal programmed atrial stimulation used up to 2 extrastimuli under baseline conditions and during Isuprel infusion </plain></SENT>
<SENT sid="7" pm="."><plain>The following results were obtained: sustained atrial <z:hpo ids='HP_0001649'>tachycardia</z:hpo> (&gt; 1 min) was induced in <z:hpo ids='HP_0000001'>all</z:hpo> patients of group 1, 3 of them also presented inducible junctional <z:hpo ids='HP_0001649'>tachycardias</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>14 patients of group II (27%) presented inducible <z:hpo ids='HP_0004755'>supraventricular tachycardia</z:hpo>: atrial <z:hpo ids='HP_0001649'>tachycardia</z:hpo> in 7 cases </plain></SENT>
<SENT sid="9" pm="."><plain>Patients in group II with inducible AT presented either <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> (n = 3) or minor abnormalities on the Holter recording (runs of <z:e sem="disease" ids="C0033036" disease_type="Disease or Syndrome" abbrv="">atrial premature complexes</z:e> or sinus pauses (n = 3) </plain></SENT>
<SENT sid="10" pm="."><plain>Two of these patients subsequently developed sustained <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> during follow-up </plain></SENT>
<SENT sid="11" pm="."><plain>In 25 patients with <z:mpath ids='MPATH_458'>normal</z:mpath> Holter recording and no <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e>, programmed atrial stimulation induced junctional <z:hpo ids='HP_0001649'>tachycardia</z:hpo> in 4 cases </plain></SENT>
<SENT sid="12" pm="."><plain>In conclusion, transoesophageal electrophysiological investigation is a useful way to identify various forms of <z:hpo ids='HP_0004755'>supraventricular tachycardia</z:hpo> able to explain an embolic <z:hpo ids='HP_0001297'>cerebrovascular accident</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>The considerable incidence of inducible AV nodal reentrant junctional <z:hpo ids='HP_0001649'>tachycardia</z:hpo> must be emphasized, while the incidence of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> is much lower than during intracardiac investigations </plain></SENT>
</text></document>